Skip to content
ClinCalc Pro
Menu
paediatrics

Modified Asthma Predictive Index (mAPI) for Children

Identifies young children (≤ 3 years) with recurrent wheeze at high risk of persistent asthma at school age. Modified API (PEAK trial / COAST cohort) of the original Tucson Asthma Predictive Index.

Used in: Asthma

Score interpretation

Negative API -- Low Risk of Persistent Asthma 0

API negative -- low probability of persistent asthma by school age

→ Reassurance: most early wheezers do not have persistent asthma; avoid unnecessary inhaled corticosteroids; short-acting bronchodilator via spacer for acute episodes; re-evaluate if the pattern changes.

Positive API -- High Risk of Persistent Asthma 1

mAPI positive — markedly higher likelihood of asthma at school age (Chang 2013).

→ Discuss asthma likelihood with the family; consider a trial of inhaled corticosteroid via spacer at a dose from a children's formulary; reliever via spacer as needed; allergy assessment; written asthma action plan; review with the paediatric respiratory team if poorly controlled.

Interpretation bands for the Asthma Predictive Index. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.